3 Tempat Kerja Terbaik di Indonesia pada 2024 telah Terungkap Media Outreach|23/12/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 23 Desember 2024 – Novo Nordisk, AstraZeneca, dan Diversey diakui sebagai
Top 3 Best Places to Work in Indonesia for 2024 revealed Media Outreach|19/12/202420/12/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 19 December 2024 – Novo Nordisk, AstraZeneca, and Diversey have been
Top 20 Best Places to Work in the Asia-Pacific Region for 2024 revealed Media Outreach|19/12/202420/12/2024oleh RRINEWSS SINGAPORE – Media OutReach Newswire – 19 December 2024 – The 2024 rankings for
AstraZeneca Indonesia Recognized as the Best Places to Work for Three Consecutive Years Media Outreach|30/10/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 30 October 2024 – AstraZeneca, a leading research-based
Best Places to Work Certification Celebrates Top Companies for Women in 2023 Media Outreach|16/02/2024oleh RRINEWSS NEW YORK, LONDON, SINGAPORE – Media OutReach Newswire – 15 February 2024 – Best
AstraZeneca certified Best Place to Work in Indonesia for the second consecutive year Media Outreach|06/02/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 6 February 2024 – AstraZeneca Indonesia, an
AstraZeneca mendapatkan penghargaan Best Places to Work in Indonesia selama dua tahun berturut-turut Media Outreach|05/02/202406/02/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 5 February 2024 – AstraZeneca, perusahaan farmasi
The world’s 30 Best Places to Work for 2023 revealed Media Outreach|09/01/2024oleh RRINEWSS NEW YORK/LONDON/SINGAPORE – Media OutReach Newswire – 9 January 2024 – The Best Places
The top 4 Best Places to Work in Singapore for 2023 revealed Media Outreach|08/01/2024oleh RRINEWSS SINGAPORE – Media OutReach Newswire – 8 January 2024 – Ivanhoé Cambridge, Novo Nordisk, CDPQ,
The Top 3 Best Places to Work in Indonesia for 2023 revealed Media Outreach|05/01/2024oleh RRINEWSS JAKARTA, INDONESIA – Media OutReach Newswire – 5 January 2024 – Novo Nordisk, AstraZeneca and Darya-Varia Laboratoria
